Cargando…
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
BACKGROUND: Despite the frequency of diabetes mellitus and its relationship to diabetic peripheral neuropathy (DPN) and neuropathic pain (NeP), our understanding of underlying mechanisms leading to chronic pain in diabetes remains poor. Recent evidence has demonstated a prominent role of microglial...
Autores principales: | Toth, Cory C, Jedrzejewski, Nicole M, Ellis, Connie L, Frey, William H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/ https://www.ncbi.nlm.nih.gov/pubmed/20236533 http://dx.doi.org/10.1186/1744-8069-6-16 |
Ejemplares similares
-
Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain
por: Diaz, Monica M., et al.
Publicado: (2022) -
Neuronal and microglial mechanisms of neuropathic pain
por: Zhuo, Min, et al.
Publicado: (2011) -
The importance of catastrophizing for successful pharmacological treatment of peripheral neuropathic pain
por: Toth, Cory, et al.
Publicado: (2014) -
Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2012) -
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
por: Hossain, Mohammad Zakir, et al.
Publicado: (2020)